UA 3 Proffesiynau Iechyd Perthynol, Deintyddiaeth, Nyrsio a Fferylliaeth
The Unit’s world-leading interdisciplinary research is ranked 4th in the UK with a GPA of 3.42. Impacts delivered through the research are far-reaching and varied in nature ranging from the introduction of new therapies and diagnostics, leading change in practice guidelines and standards, through to advancing and informing public-body policy initiatives. 100% of our research environment was rated as conducive to producing research of world-leading quality in terms of its vitality and sustainability. 90% of our research has been deemed ‘outstanding’ for its impact in terms of its reach and significance.
|Environment||100.0%||0.0%||0.0%||0.0%||0.0%||About the REF|
The 'Allied Health' Unit of Assessment lies within the College of Biomedical and Life Sciences. The unit comprises researchers from groups which are aligned in most cases to Academic Schools: Dentistry; Healthcare Sciences; Medicine (Institute of Molecular and Experimental Medicine); Optometry and Vision Sciences, and Pharmacy and Pharmaceutical Sciences.
Strategy is focused on delivering world-leading discoveries and healthcare benefits for human health and welfare. We build research capacity and culture by investing in facilities and staff.
Research infrastructure has benefitted from investments totalling £28m from a range of sources including direct University capital, HEFCW and others. Relocation to new purpose-built facilities (£20M) has accommodated preclinical and clinical research, and six new professorial staff enhance our research leadership.
Main achievements during the REF period include research awards totalling £60m and an income ('spend') of £41m during the assessment period - a 40% increase compared to the combined spend of the same research groups during RAE 2008.
Research is interdisciplinary spanning the full translational spectrum across three overlapping spheres of operation:-
|Spheres of operation||Scope|
|Molecular to systems-level preclinical research||Addresses mechanisms of disease, therapeutic targets and interventions (e.g. drugs, diagnostics, tissue regeneration) in a range of disease areas (dental, cancer, cardiovascular, endocrine, infection, musculoskeletal, neurological, ocular).|
|Clinical research||Integrates with the Unit's pre-clinical studies, e.g. new drug candidates, but can also be conducted independent of pre-clinical research, e.g. clinical rehabilitation research. Clinical studies are conducted both within the Unit accessing particular patient cohorts, e.g. chronic non-healing wounds, low vision special needs patients, or in conjunction with the NHS e.g. dental clinics, or externally with partners e.g. drug trials.|
|Public health/healthcare delivery research||Addresses epidemiological, quality of life, pharmacoeconomics, workforce and practice-based investigations.|
Research centres and groups
|Arthritis Research UK Biomechanics and Bioengineering Centre (ARUKBBC)||Promotes collaborations between biomedical scientists and practitioners.|
|European Cancer Stem Cell Research Institute||Improving our understanding of the role of cancer stem cells in a range of cancers, through world-leading research.|
|Neuroscience and Mental Health Research Institute||Taking new discoveries and translating them into greater understanding and diagnosis of mental illness.|
|1||University of Sheffield B||3.51|
|2||Swansea University A||3.49|
|3||University of Southampton||3.47|
|4||University of Nottingham A||3.42|
|6||University of Bath||3.41|
|7||University of Manchester||3.38|
|8||University of Surrey||3.37|
|10||Queen's University of Belfast A||3.36|
Table continues to 94